Company Search:
Advanced Search
Sponsored Links
Hikal Ltd Company Snapshot
Hikal Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hikal Ltd with three other companies in this sector in INDIA : FDC Ltd (2021 sales of 13.33 billion Indian Rupees [US$181.72 million] ), Marksans Pharma Limited (13.76 billion Indian Rupees [US$187.57 million] ), and Dishman Carbogen Amcis Ltd (19.12 billion Indian Rupees [US$260.61 million] ).

Sales Analysis. Hikal Ltd reported sales of 17.20 billion Indian Rupees (US$234.50 million) for the fiscal year ending March of 2021. This represents an increase of 14.1% versus 2020, when the company's sales were 15.07 billion Indian Rupees .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hikal Ltd
  Stock Performance Chart for Hikal Ltd
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 469.35
(Figures in Indian Rupees )
1 Week 6.0%   13 Weeks 38.9%  
4 Weeks 194.9%   52 Weeks 303.2%  
Hikal Ltd Key Data:
  Ticker: HIKAL Country: India
  Exchanges: OTH BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2021 Sales 17,204,400,000
(Year Ending Jan 2022).
Employees: 1,629
  Currency: Indian Rupees Market Cap: 57,871,207,013
  Fiscal Yr Ends: March Shares Outstanding: 123,300,750
  Share Type: Ordinary Closely Held Shares: 85,039,723
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.